HealthMore in Health →
Eli Lilly’s $4.5 Billion Indiana Bet Expands the U.S. Pharma Manufacturing Buildout
Eli Lilly plans $4.5 billion in new manufacturing investments across Indiana, adding to the wave of domestic life-sciences capacity expansion as drugmakers push more production into the United States.
Key Takeaways
- Eli Lilly plans $4.5 billion in manufacturing investments across Indiana.
- Endpoints frames the move within a broader wave of U.S. drugmaker projects.
DE
DT Editorial AI··via endpoints.news